Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos
Background Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome. Methods Data from 13,006 participants aged 18 to 74 years in the Hispanic Communit...
Saved in:
| Published in | BMC nephrology Vol. 22; no. 1; pp. 302 - 11 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
07.09.2021
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2369 1471-2369 |
| DOI | 10.1186/s12882-021-02483-y |
Cover
| Abstract | Background
Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome.
Methods
Data from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m
2
based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome.
Results
Mean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates.
Conclusions
In this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD. |
|---|---|
| AbstractList | Background Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome. Methods Data from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m.sup.2 based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome. Results Mean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates. Conclusions In this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD. Keywords: NAFLD, Chronic kidney disease, Obesity, Race/ethnicity, Aminotransferase levels, Hispanics/Latinos Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome.BACKGROUNDPrevious studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome.Data from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m2 based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome.METHODSData from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m2 based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome.Mean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates.RESULTSMean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates.In this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD.CONCLUSIONSIn this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD. Background Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome. Methods Data from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m2 based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome. Results Mean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates. Conclusions In this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD. Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome. Data from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m.sup.2 based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome. Mean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates. In this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD. Background Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome. Methods Data from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m 2 based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome. Results Mean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates. Conclusions In this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD. Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome. Data from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome. Mean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates. In this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD. Abstract Background Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome. Methods Data from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m2 based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome. Results Mean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates. Conclusions In this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD. |
| ArticleNumber | 302 |
| Audience | Academic |
| Author | Lash, James P. Raij, Leopoldo Cai, Jianwen Talavera, Gregory A. Pirzada, Amber Kuniholm, Mark H. Kallwitz, Eric Durazo-Arvizu, Ramon Kramer, Holly Cotler, Scott J. Rosas, Sylvia E. Missikpode, Celestin Ricardo, Ana C. Daviglus, Martha L. |
| Author_xml | – sequence: 1 givenname: Celestin surname: Missikpode fullname: Missikpode, Celestin email: celesmis@uic.edu organization: Institute for Minority Health Research, University of Illinois at Chicago – sequence: 2 givenname: Holly surname: Kramer fullname: Kramer, Holly organization: Department of Medicine, Division of Nephrology and Hypertension, Loyola University Chicago Health Sciences Campus, Department of Public Health Sciences, Loyola University Chicago Health Sciences Campus – sequence: 3 givenname: Scott J. surname: Cotler fullname: Cotler, Scott J. organization: Department of Medicine, Division of Hepatology, Loyola University Chicago Health Sciences Campus – sequence: 4 givenname: Ramon surname: Durazo-Arvizu fullname: Durazo-Arvizu, Ramon organization: Department of Public Health Sciences, Loyola University Chicago Health Sciences Campus – sequence: 5 givenname: James P. surname: Lash fullname: Lash, James P. organization: Department of Medicine, University of Illinois at Chicago – sequence: 6 givenname: Eric surname: Kallwitz fullname: Kallwitz, Eric organization: Department of Medicine, Division of Hepatology, Loyola University Chicago Health Sciences Campus – sequence: 7 givenname: Jianwen surname: Cai fullname: Cai, Jianwen organization: Collaborative Studies Coordinating Center, Department of Biostatistics, University of North Carolina at Chapel Hill – sequence: 8 givenname: Mark H. surname: Kuniholm fullname: Kuniholm, Mark H. organization: Department of Epidemiology and Biostatistics, University at Albany – sequence: 9 givenname: Sylvia E. surname: Rosas fullname: Rosas, Sylvia E. organization: Kidney and Hypertension Unit, Joslin Diabetes Center, Harvard Medical School – sequence: 10 givenname: Ana C. surname: Ricardo fullname: Ricardo, Ana C. organization: Department of Medicine, University of Illinois at Chicago – sequence: 11 givenname: Gregory A. surname: Talavera fullname: Talavera, Gregory A. organization: South Bay Latino Research Center, Graduate School of Public Health, San Diego State University – sequence: 12 givenname: Leopoldo surname: Raij fullname: Raij, Leopoldo organization: Department of Medicine, Division of Nephrology and Hypertension, University of Miami Miller School of Medicine – sequence: 13 givenname: Amber surname: Pirzada fullname: Pirzada, Amber organization: Institute for Minority Health Research, University of Illinois at Chicago – sequence: 14 givenname: Martha L. surname: Daviglus fullname: Daviglus, Martha L. organization: Institute for Minority Health Research, University of Illinois at Chicago |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34493216$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstq3DAUhk1JaS7tC3RRDN1040RXW-6iMIReAoFu2rWQpeMZTW1pKtkJfoc-dOVxmmRCCcaykb7_Pz7H_2l25LyDLHuL0TnGoryImAhBCkRwupmgxfQiO8GswgWhZX306P04O41xixCuBEOvsmPKWE0JLk-yP6sYvbZqsN7lvs2hgxs1gMkjhLHPVW-dH4JysYWgIuTpGLqY39phk-tN8M7q_Jc1Dqbc2Agz0qd1DBA_5hsbd2omtO_70dlhyjeguiSNw2imi_06V-1Sfefj6-xlq7oIb-6eZ9nPL59_XH4rrr9_vbpcXRe6RNVQEFRizCnmjVICgRGc8RJxTChpqGGcUSDAteCEVrwpSU1IYzBgU2tmWkbpWXa1-BqvtnIXbK_CJL2ycr_hw1qqMFjdgSQ1V0IxXFNBWFklU1QZzaARlcItapLXp8VrNzY9GA0ujas7MD08cXYj1_5GCkZISVEy-HBnEPzvEeIgexs1dJ1y4McoCa8QrQgRPKHvn6BbPwaXRjVTjDFCKX2g1io1YF07_0A9m8pVWaWhsJKSRJ3_h0qXgd7qFLTWpv0DwbvHjd53-C9LCSALoIOPMUB7j2Ak58DKJbAyBVbuAyunJBJPRNoO-zSmz7Hd81K6SGOq49YQHqbxjOov0aoAwg |
| CitedBy_id | crossref_primary_10_1007_s00592_023_02058_3 crossref_primary_10_1038_s41598_022_12004_y crossref_primary_10_3390_ijms232113320 |
| Cites_doi | 10.1056/NEJMoa1114248 10.1002/hep.24283 10.1016/j.annepidem.2007.05.013 10.1002/hep.20466 10.1002/hep.27395 10.1161/circ.106.25.3143 10.1681/ASN.2015050570 10.1016/j.annepidem.2010.03.015 10.1016/j.cgh.2014.08.037 10.1016/j.metabol.2017.11.003 10.1111/j.1440-1746.2006.04639.x 10.1681/ASN.V1341034 10.1016/j.diabres.2020.108358 10.25011/cim.v35i4.17153 10.2337/diacare.23.1.57 10.1159/000343885 10.1053/jhep.2003.50193 10.1111/apt.13860 10.1002/hep.21178 10.1002/hep.26716 10.1016/j.metabol.2007.11.022 10.1016/j.cld.2007.02.011 10.1016/j.dld.2021.02.010 10.1074/jbc.M111.290114 10.1016/j.jhep.2017.09.020 10.1016/j.cgh.2011.03.020 10.1056/NEJMcp044370 10.1016/j.ajhg.2008.09.012 10.1186/1471-230X-6-33 10.1001/jama.289.19.2560 10.1210/er.2008-0009 10.2215/CJN.02020215 10.1007/s00125-010-1720-1 10.1111/j.1572-0241.2003.07486.x 10.1016/j.cgh.2017.09.041 10.1016/j.annepidem.2010.05.006 10.1136/jmg.2009.066597 10.1093/aje/155.12.1114 10.1038/ng.257 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 2021. The Author(s). COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: 2021. The Author(s). – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12882-021-02483-y |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) ProQuest - Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2369 |
| EndPage | 11 |
| ExternalDocumentID | oai_doaj_org_article_295a8a419382467c8507dc4eb87a1f0b PMC8422630 A675234632 34493216 10_1186_s12882_021_02483_y |
| Genre | Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: T32 HL125294 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c607t-206115315baa80ed85456051232b3d4543e2e5c852375b62922bd1e1d9c4df433 |
| IEDL.DBID | M48 |
| ISSN | 1471-2369 |
| IngestDate | Wed Aug 27 01:25:05 EDT 2025 Thu Aug 21 14:11:21 EDT 2025 Sun Aug 24 03:40:49 EDT 2025 Fri Jul 25 21:19:20 EDT 2025 Tue Jun 17 21:03:16 EDT 2025 Tue Jun 10 20:49:27 EDT 2025 Thu Jan 02 22:55:46 EST 2025 Thu Apr 24 22:53:29 EDT 2025 Tue Jul 01 02:25:14 EDT 2025 Sat Sep 06 07:22:13 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Obesity NAFLD Chronic kidney disease Aminotransferase levels Race/ethnicity Hispanics/Latinos |
| Language | English |
| License | 2021. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-206115315baa80ed85456051232b3d4543e2e5c852375b62922bd1e1d9c4df433 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12882-021-02483-y |
| PMID | 34493216 |
| PQID | 2574442333 |
| PQPubID | 44769 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_295a8a419382467c8507dc4eb87a1f0b pubmedcentral_primary_oai_pubmedcentral_nih_gov_8422630 proquest_miscellaneous_2570372285 proquest_journals_2574442333 gale_infotracmisc_A675234632 gale_infotracacademiconefile_A675234632 pubmed_primary_34493216 crossref_primary_10_1186_s12882_021_02483_y crossref_citationtrail_10_1186_s12882_021_02483_y springer_journals_10_1186_s12882_021_02483_y |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-09-07 |
| PublicationDateYYYYMMDD | 2021-09-07 |
| PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-07 day: 07 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC nephrology |
| PublicationTitleAbbrev | BMC Nephrol |
| PublicationTitleAlternate | BMC Nephrol |
| PublicationYear | 2021 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | AC Ricardo (2483_CR6) 2015; 10 SH Caldwell (2483_CR28) 2007; 22 X Yuan (2483_CR37) 2008; 83 M Maximos (2483_CR42) 2015; 61 JM Clark (2483_CR43) 2003; 98 A Mantovani (2483_CR9) 2018; 79 L Kopin (2483_CR24) 2017; 167 N Stefan (2483_CR29) 2008; 29 HC Hong (2483_CR40) 2014; 59 RK Sterling (2483_CR16) 2006; 43 2483_CR32 2483_CR13 LA Adams (2483_CR41) 2007; 17 J Edmison (2483_CR30) 2007; 11 2483_CR39 G Bedogni (2483_CR15) 2006; 6 E Vilar-Gomez (2483_CR34) 2017; 45 ER Kallwitz (2483_CR14) 2015; 13 MW Yeung (2483_CR33) 2018; 68 2483_CR31 LA Inker (2483_CR18) 2012; 367 S Ciardullo (2483_CR17) 2020; 167 MD Ashen (2483_CR23) 2005; 353 NE Rich (2483_CR3) 2018; 16 Y Chang (2483_CR8) 2008; 57 CM Lora (2483_CR4) 2009; 19 AV Chobanian (2483_CR21) 2003; 289 JC Sirota (2483_CR10) 2012; 36 LM LaVange (2483_CR12) 2010; 20 American Diabetes Association (2483_CR22) 2016; 39 DR Jacobs Jr (2483_CR19) 2002; 155 PD Sorlie (2483_CR11) 2010; 20 S Sookoian (2483_CR38) 2011; 53 B Kollerits (2483_CR36) 2010; 47 MJ Fischer (2483_CR5) 2016; 27 G Targher (2483_CR7) 2010; 53 HJ Mattix (2483_CR20) 2002; 13 E Bonora (2483_CR25) 2000; 23 Y Huang (2483_CR35) 2011; 286 National Cholesterol Education Program (NCEP) (2483_CR27) 2002; 106 ZM Younossi (2483_CR1) 2011; 9 JD Browning (2483_CR2) 2004; 40 S Romeo (2483_CR26) 2008; 40 |
| References_xml | – volume: 367 start-page: 20 issue: 1 year: 2012 ident: 2483_CR18 publication-title: New England Journal of Medicine doi: 10.1056/NEJMoa1114248 – volume: 53 start-page: 1883 issue: 6 year: 2011 ident: 2483_CR38 publication-title: Hepatology doi: 10.1002/hep.24283 – volume: 17 start-page: 863 issue: 11 year: 2007 ident: 2483_CR41 publication-title: Annals of epidemiology doi: 10.1016/j.annepidem.2007.05.013 – volume: 40 start-page: 1387 issue: 6 year: 2004 ident: 2483_CR2 publication-title: Hepatology doi: 10.1002/hep.20466 – volume: 61 start-page: 153 issue: 1 year: 2015 ident: 2483_CR42 publication-title: Hepatology doi: 10.1002/hep.27395 – volume: 106 start-page: 3143 issue: 25 year: 2002 ident: 2483_CR27 publication-title: Circulation doi: 10.1161/circ.106.25.3143 – volume: 27 start-page: 3488 issue: 11 year: 2016 ident: 2483_CR5 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2015050570 – volume: 20 start-page: 629 issue: 8 year: 2010 ident: 2483_CR11 publication-title: Annals of epidemiology doi: 10.1016/j.annepidem.2010.03.015 – volume: 13 start-page: 569 issue: 3 year: 2015 ident: 2483_CR14 publication-title: Clinical Gastroenterology and Hepatology doi: 10.1016/j.cgh.2014.08.037 – volume: 79 start-page: 64 year: 2018 ident: 2483_CR9 publication-title: Metabolism doi: 10.1016/j.metabol.2017.11.003 – volume: 22 start-page: S11-S19 year: 2007 ident: 2483_CR28 publication-title: Journal of gastroenterology and hepatology doi: 10.1111/j.1440-1746.2006.04639.x – volume: 13 start-page: 1034 issue: 4 year: 2002 ident: 2483_CR20 publication-title: Journal of the American Society of Nephrology doi: 10.1681/ASN.V1341034 – volume: 167 start-page: 108358 year: 2020 ident: 2483_CR17 publication-title: Diabetes Research and Clinical Practice doi: 10.1016/j.diabres.2020.108358 – ident: 2483_CR39 doi: 10.25011/cim.v35i4.17153 – volume: 23 start-page: 57 issue: 1 year: 2000 ident: 2483_CR25 publication-title: Diabetes care doi: 10.2337/diacare.23.1.57 – volume: 36 start-page: 466 issue: 5 year: 2012 ident: 2483_CR10 publication-title: American journal of nephrology doi: 10.1159/000343885 – ident: 2483_CR31 doi: 10.1053/jhep.2003.50193 – volume: 45 start-page: 332 issue: 2 year: 2017 ident: 2483_CR34 publication-title: Alimentary pharmacology & therapeutics doi: 10.1111/apt.13860 – volume: 43 start-page: 1317 issue: 6 year: 2006 ident: 2483_CR16 publication-title: Hepatology doi: 10.1002/hep.21178 – volume: 59 start-page: 1772 issue: 5 year: 2014 ident: 2483_CR40 publication-title: Hepatology doi: 10.1002/hep.26716 – volume: 19 start-page: 466 issue: 4 year: 2009 ident: 2483_CR4 publication-title: Ethnicity & disease – volume: 57 start-page: 569 issue: 4 year: 2008 ident: 2483_CR8 publication-title: Metabolism doi: 10.1016/j.metabol.2007.11.022 – ident: 2483_CR13 – volume: 11 start-page: 75 issue: 1 year: 2007 ident: 2483_CR30 publication-title: Clinics in liver disease doi: 10.1016/j.cld.2007.02.011 – ident: 2483_CR32 doi: 10.1016/j.dld.2021.02.010 – volume: 286 start-page: 37085 issue: 43 year: 2011 ident: 2483_CR35 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M111.290114 – volume: 68 start-page: 147 issue: 1 year: 2018 ident: 2483_CR33 publication-title: Journal of hepatology doi: 10.1016/j.jhep.2017.09.020 – volume: 167 start-page: ITC81-ITC96 issue: 11 year: 2017 ident: 2483_CR24 publication-title: Dyslipidemia. Annals of internal medicine – volume: 9 start-page: 524 issue: 6 year: 2011 ident: 2483_CR1 publication-title: Clinical Gastroenterology and Hepatology doi: 10.1016/j.cgh.2011.03.020 – volume: 353 start-page: 1252 issue: 12 year: 2005 ident: 2483_CR23 publication-title: New England Journal of Medicine doi: 10.1056/NEJMcp044370 – volume: 83 start-page: 520 issue: 4 year: 2008 ident: 2483_CR37 publication-title: The American Journal of Human Genetics doi: 10.1016/j.ajhg.2008.09.012 – volume: 6 start-page: 1 issue: 1 year: 2006 ident: 2483_CR15 publication-title: BMC gastroenterology doi: 10.1186/1471-230X-6-33 – volume: 289 start-page: 2560 year: 2003 ident: 2483_CR21 publication-title: Jama doi: 10.1001/jama.289.19.2560 – volume: 29 start-page: 939 issue: 7 year: 2008 ident: 2483_CR29 publication-title: Endocrine reviews doi: 10.1210/er.2008-0009 – volume: 10 start-page: 1757 issue: 10 year: 2015 ident: 2483_CR6 publication-title: Clinical Journal of the American Society of Nephrology doi: 10.2215/CJN.02020215 – volume: 53 start-page: 1341 issue: 7 year: 2010 ident: 2483_CR7 publication-title: Diabetologia doi: 10.1007/s00125-010-1720-1 – volume: 98 start-page: 960 issue: 5 year: 2003 ident: 2483_CR43 publication-title: The American journal of gastroenterology doi: 10.1111/j.1572-0241.2003.07486.x – volume: 16 start-page: 198 issue: 2 year: 2018 ident: 2483_CR3 publication-title: Clinical Gastroenterology and Hepatology doi: 10.1016/j.cgh.2017.09.041 – volume: 20 start-page: 642 issue: 8 year: 2010 ident: 2483_CR12 publication-title: Annals of epidemiology doi: 10.1016/j.annepidem.2010.05.006 – volume: 47 start-page: 116 issue: 2 year: 2010 ident: 2483_CR36 publication-title: J Med Genetics doi: 10.1136/jmg.2009.066597 – volume: 155 start-page: 1114 issue: 12 year: 2002 ident: 2483_CR19 publication-title: American journal of epidemiology doi: 10.1093/aje/155.12.1114 – volume: 39 start-page: S13-S22 issue: Supplement 1 year: 2016 ident: 2483_CR22 publication-title: Diabetes care – volume: 40 start-page: 1461 issue: 12 year: 2008 ident: 2483_CR26 publication-title: Nature genetics doi: 10.1038/ng.257 |
| SSID | ssj0017840 |
| Score | 2.2698765 |
| Snippet | Background
Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear... Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the... Background Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear... Abstract Background Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 302 |
| SubjectTerms | Adult Alanine Alanine transaminase Alanine Transaminase - blood Albuminuria Alcohol use Alcoholism Aminotransferase levels Aminotransferases Aspartate aminotransferase Aspartate Aminotransferases - blood Blood pressure Chronic kidney disease Chronic kidney failure Cohort Studies Complications and side effects Creatinine Creatinine - urine Cystatin C Diabetes Diagnosis Enzymes Epidermal growth factor receptors Fatty liver Female Glomerular Filtration Rate Glucose Health aspects Health insurance Hepatitis Hispanic Americans Hispanic or Latino Hispanics/Latinos Humans Insulin resistance Internal Medicine Kidney diseases Liver diseases Logistic Models Male Measurement Medicine Medicine & Public Health Metabolic syndrome Metabolic Syndrome - complications Metabolic Syndrome - ethnology NAFLD Nephrology Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - ethnology Obesity Odds Ratio Population Race/ethnicity Renal Insufficiency, Chronic - blood Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - ethnology Risk Factors Secondary schools Steroids Transferrins Triglycerides Urine Womens health |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICMhcYBoE7_icCuIqkIqJyr1Zvm16opugprsYf9Df3RnnGTZFAEXLnuIHa3t-Wb8TTwzJuRtKb0rXKhzjfRNoLujK7bMfamkdbWyRY3ZyKff1MmZ-Houz_eu-sKYsKE88LBwC1ZLq60AnqEZKLXXQGCCF9HpypbLwqH1LepicqbG84MK_JYpRUarRQdWGIaC4QhYw4vn29k2lKr1_26T9zal2wGTt05N02Z0_IDcH1kkPRpG_5Dcic0jcvd0PCd_TK73Vp22S4pJ5EAqAwXAbdbUrldN2yfKGq9gG6OXGDrUUfwoS_1QLpf-WIUmbul4gkPXw8fE7iO9WIEVwh5-SC7pt3TIpqSpVu0i_eK_Yphd03ZPyNnxl--fT_Lx3oXcq6LqQXEU8EReSmetLmLQyLJAeYF8OR6EFDyyKEESjFfSKVYz5kIZy1B7EZaC86fkoGmb-JxQZX3tKl77ELUIDvnGMkoFcBAKuKnNSDmJwfixKDnejXFpknOilRlEZ0B0JonObDPyfvfOz6Ekx197f0Lp7npiOe30AEBmRpCZf4EsI-8QGwaVHobn7Zi7AJPE8lnmCNwuxoXiLCOHs56grH7ePKHLjMaiM2A1hQBay3lG3uya8U0MgGtiu0l9Cl4xpmVGng1g3E2JCwEsvFQZqWYwnc153tKsLlIpcY2J1LzIyIcJ0L-G9ec1ffE_1vQluceSQmIS3SE56K828RUQvN69Trp8A_F0S8k priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLdgSIgL4puMgYyExAGiJrZjO1zQQEwT0jgxqTfLX2UVazKa9tD_YX807zlptwyxSw-xo9p5X79nvw9C3pWVd4ULda4Rvgl0d7Ris9yXsrKulraoMRv55Ic8PhXfp9V0OHDrhrDKrU5Mijq0Hs_IJ8BaQoDt5_zzxZ8cu0bh7erQQuMuuVcCEsHWDWq6c7hKBd7LNlFGy0kHuhgWhEEJWMmL55uRMUo1-__VzNdM082wyRt3p8kkHT0iDwcsSQ974j8md2LzhNw_GW7Ln5LLa9-etjOKqeQALQMFtlsvqF3Mm3aVgGtcgjGj5xhA1FE8mqW-L5pLf89DEzd0uMehi_5IsftEz-agi3CG71NMVhva51TSVLF2kn7xXzHYrmm7Z-T06NvPr8f50H0h97JQKxAfCWiRl5WzVhcxaMRaIMIAwRwPohI8slh5DZ6sqpxkNWMulLEMtRdhJjh_TvaatokvCZXW107x2oeoRXCIOmaxksAUQgJCtRkpt2QwfihNjh0yzk1yUbQ0PekMkM4k0plNRj7s3rnoC3PcOvsLUnc3E4tqpwft8pcZZNSwurLaCmAkDQtTsLVCBS-i08qWs8Jl5D3yhkHRh-V5O2QwwCaxiJY5BOeLcSE5y8jBaCaIrB8Pb7nLDCqjM1cMnpG3u2F8E8Pgmtiu05yCK8Z0lZEXPTPutsSFACxeyoyoEZuO9jweaeZnqaC4xnRqXmTk45ahr5b1_2-6f_suXpEHLIkaJskdkL3Vch1fA4BbuTdJSv8Cn6pD1Q priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jb9QwFLagSIgLYm_agoyExAGiJt7icCsjqgqpnKjUm-Ut6ohOBjUzh_kP_GjeczJhUhaJyxzi54ydt_h7eUsIeVNK7woX6lwjfBPo7uiKNbkvlbSuVraosRr5_Is6uxCfL-Xl0CYHa2F24_elVscd2E-4CSYSYPctnm_uknsSDC9K80zNxohBBZ7Ktijmj_MmB0_qz_-7Fd45hm6nSN6Kk6bj5_QReTjgRnrSM_oxuRPbJ-T--RAZf0p-7Dxnumwolo0DjAwURGy9oHYxb5erBFLjDRxc9BqThTqKr2Gp7xvk0m_z0MYNHWI2dNG_Puw-0Ks52B2k8H05yWpD-_pJmrrTHqdf_FdMrGuX3TNycfrp6-wsH760kHtVVCtQFQXIkJfSWauLGDTiKlBXgFuOByEFjyxKr8FrraRTrGbMhTKWofYiNILz52SvXbZxn1Blfe0qXvsQtQgOEUYTpQIBEArQqM1IuWWD8UMbcvwaxrVJ7ohWpmedAdaZxDqzyci7cc73vgnHP6k_IndHSmygnS6AXJlBHw2rpdVWAHzVsLAKtlZUwYvodGXLpnAZeYuyYVDNYXneDtUKsElsmGVOwNFiXCjOMnI0oQT19NPhrXSZwTx0BuykEABkOc_I63EYZ2LKWxuX60RT8IoxLTPyohfGcUtcCMDdpcpINRHTyZ6nI-38KjUP11g6zYuMvN8K9K9l_f2ZHvwf-SF5wJLqYYHcEdlb3azjSwBvK_cqae1P-0U9Rg priority: 102 providerName: Springer Nature |
| Title | Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos |
| URI | https://link.springer.com/article/10.1186/s12882-021-02483-y https://www.ncbi.nlm.nih.gov/pubmed/34493216 https://www.proquest.com/docview/2574442333 https://www.proquest.com/docview/2570372285 https://pubmed.ncbi.nlm.nih.gov/PMC8422630 https://doaj.org/article/295a8a419382467c8507dc4eb87a1f0b |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA57AfFFvFtdhwiCDzpu26RJKojMDrssA7uIOjBvoUlTd3Cm1bmA8x_80Z6TtrPbdfXJlxaahCY55yTfybmEkJdRYk1o8rSvEL5xVHeUjIu-jUSSmVRkYYrRyGfn4nTMR5NkskPa646aCVzeqNrhfVLjxeztzx-bDyDw773AK3G4hDUWfoTOBpihi_U3u2Tf24vQlY9fWhUkaDNt4MyN7Tqbk8_h_-dKfWWruu5Gec2W6reok7vkToMt6aBmhntkx5X3ya2zxnr-gPy6QgtaFRRDywFq5hTYcD2n2XxaVisPZN0CNjc6Q4eiJcWjWmrrJLr02zQv3YY2dh06r48Yl-_oxRTWJqxh65CT1YbWMZbUZ7A99E_8KzrfldXyIRmfHH8Znvab2xj6VoRyBeIkAD2yKDFZpkKXK8ReINIAyQzLecKZi11iFWi2MjEiTuPY5JGL8tTyvOCMPSJ7ZVW6J4SKzKZGstTmTvHcIAopXCKASbgAxJoFJGrJoG2TqhxvzJhpr7IooWvSaSCd9qTTm4C83rb5Xifq-GftI6TutiYm2fYfqsVX3cisjtMkUxkHiKugYxKGFsrccmeUzKIiNAF5hbyhkTmhezZrIhpgkJhUSw9AGYsZFywOyEGnJoiw7Ra33KVbCdCwlnIOYJexgLzYFmNLdIsrXbX2dUIm41glAXlcM-N2SIxzwOaRCIjssGlnzN2ScnrhE4wrDK9mYUDetAx92a2_z-nT_zGnz8jt2AskhtYdkL3VYu2eA-xbmR7ZlRPZI_uDwejzCN5Hx-cfP8HXoRj2_FFKz0v7bxNiWeM |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTgJeEHcCA4wE4gGiJo7jOEgT2mBTx9YKoU3am0lsl1WsyWhaof4HfhO_jXOcpFuG2Nte-hA7qk_O53Oxz4WQV2Gs8yA3qS_RfOPo7siEjX0dijjLU5EFKWYjD0dicMQ_H8fHa-RPmwuDYZWtTHSC2pQaz8j7AC3OQfdH0Yeznz52jcLb1baFRta0VjCbrsRYk9ixb5e_wIWrNvc-Ab9fM7a7c_hx4DddBnwtgmQOMBFgFUVhnGeZDKyRaFMAVMHUyCPDYx5ZZmMtwWNL4lywlLHchDY0qeZmzPFAFFTAOscDlB5Z394Zffm6usdIwH9qU3Wk6FegDeCTYFgE1hKL_GVHHbquAf_qhgvK8XLg5qXbW6cUd--Q2401S7dq-N0la7a4R24Mm_v6--T3Be7TckwxmR2MW0MB-IspzaaTopw709nOQJ3SUwxhqigeDlNdl-2lPyamsEva3CTRaX2oWb2nJxOQhjhD10ku8yWtszqpq5nbd7_4rxjuV5TVA3J0LZx5SHpFWdjHhIpMp3kSpdpYyU2Ods_YxgJgyQXYyJlHwpYNSjfF0bFHx6lyTpIUqmadAtYpxzq19Mjb1TtndWmQK2dvI3dXM7Gst3tQzr6rRkoolsaZzDgY1RIWlgBpQWI0t7lMsnAc5B55g9hQKHxgeTprciiASCzjpbbA_WMRFxHzyEZnJggN3R1u0aUaoVWp8y3mkZerYXwTA_EKWy7cnCBKGJOxRx7VYFyRFHEO3kAoPJJ0YNqhuTtSTE5cSXOJCd1R4JF3LaDPl_X_b_rkaipekJuDw-GBOtgb7T8lt5jbdpiyt0F689nCPgNzcp4_b_YsJd-uW0z8BT4rhKM |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZgkyZe0LgubICRkHiAqknsOA5v5VKNwiYkmLQ3y7ewijWZ2vSh_4EfzTlOWppxkXjpQ3yc2jkXfyfnEkKeJ5k1sXHFQCJ84-juyDwtBzYRmTaF0HGB1cgnp-L4jE_Os_OtKv6Q7b4OSbY1DdilqWqGV65sVVyK4QKsKtwa0wuwJxcbrG6SXZkVBbhfu6PR5MtkE0nIwYNZF8v8cWbvQAp9-3-3zlvH0_XUyWvx03AsjffJ7Q5P0lErAHfIDV_dJXsnXcT8Hvmx9fxpXVIsJwd46SiI3nJG9Wxa1U0Ar34OBxq9xCSiBcXXs9S2jXPp96mr_Ip2sRw6a18rLl7TiynYI6SwbZlJs6JtXSUNXWuH4Rf_FRPuqnpxn5yN3399ezzovsAwsCLOG1AhAYiRJZnRWsbeScRboMYAwwxzPOPMpz6zErzZPDMiLdLUuMQnrrDclZyxB2Snqit_QKjQtjA5K6zzkjuDyKP0mQDB4AJQqo5IsmaDsl17cvxKxqUKbooUqmWdAtapwDq1isjLzZyrtjnHP6nfIHc3lNhYO1yo599Up6cqLTItNQdYK2FhOWwtzp3l3shcJ2VsIvICZUOh-sPyrO6qGGCT2EhLjcABSxkXLI3IUY8S1Nb2h9fSpTqzsVBgPzkHgMtYRJ5thnEmpsJVvl4GmpjlaSqziDxshXGzJcY54PFERCTviWlvz_2RanoRmopLLKlmcURerQX617L-_kwf_R_5U7L3-d1Yffpw-vGQ3EqDFmIN3RHZaeZL_xjwXWOedCr8E1ILSfM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+elevated+serum+aminotransferase+levels+with+chronic+kidney+disease+measures%3A+hispanic+community+health+study%2Fstudy+of+latinos&rft.jtitle=BMC+nephrology&rft.au=Celestin+Missikpode&rft.au=Holly+Kramer&rft.au=Scott+J.+Cotler&rft.au=Ramon+Durazo-Arvizu&rft.date=2021-09-07&rft.pub=BMC&rft.eissn=1471-2369&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=11&rft_id=info:doi/10.1186%2Fs12882-021-02483-y&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_295a8a419382467c8507dc4eb87a1f0b |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2369&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2369&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2369&client=summon |